Ship Healthcare Holdings, Inc. (TSE:3360) just released its latest half-year results and things are looking bullish. Ship Healthcare Holdings beat earnings, with revenues hitting JP¥186b, ahead of expectations, and statutory earnings per share outperforming analyst reckonings by a solid 13%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Ship Healthcare Holdings after the latest results.
Taking into account the latest results, Ship Healthcare Holdings' three analysts currently expect revenues in 2027 to be JP¥739.4b, approximately in line with the last 12 months. Statutory earnings per share are predicted to climb 15% to JP¥179. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥739.4b and earnings per share (EPS) of JP¥175 in 2027. So the consensus seems to have become somewhat more optimistic on Ship Healthcare Holdings' earnings potential following these results.
Check out our latest analysis for Ship Healthcare Holdings
There's been no major changes to the consensus price target of JP¥2,703, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on Ship Healthcare Holdings, with the most bullish analyst valuing it at JP¥3,380 and the most bearish at JP¥2,230 per share. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.
Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 2.0% by the end of 2027. This indicates a significant reduction from annual growth of 8.0% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 3.9% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Ship Healthcare Holdings is expected to lag the wider industry.
The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Ship Healthcare Holdings' earnings potential next year. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at JP¥2,703, with the latest estimates not enough to have an impact on their price targets.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Ship Healthcare Holdings going out to 2029, and you can see them free on our platform here.
Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.